Clinical and radiographic outcomes of extreme lateral approach to interbody fusion with β-tricalcium phosphate and hydroxyapatite composite for lumbar degenerative conditions

International Journal of Spine Surgery

Volumn 6, Issue 1, 2012, Pages 24-28

  Rodgers, W Blake ^a   Gerber, Edward J ^a   Rodgers, Jody A ^a  

^a Spine Midwest   (United States)

Author keywords

Tricalcium phosphate; BMA; Graft; Lumbar fusion; Obese; Spine; Synthetic

Indexed keywords

CALCIUM PHOSPHATE; HYDROXYAPATITE;

ADULT; ARTICLE; BLEEDING; BODY MASS; BONE ATROPHY; BONE GRAFT; BONE MARROW BIOPSY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; ILIAC CREST; LUMBAR SPINE; MALE; OSWESTRY DISABILITY INDEX; PRIORITY JOURNAL; SHORT FORM 36; SPINE FUSION; VISUAL ANALOG SCALE;

EID: 84870030284     PISSN: 22114599     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsp.2011.10.001     Document Type: Article

References (22)

1. Ozgur B.M., Aryan H.E., Pimenta L., Taylor W.R. Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J 2006, 6:435-443.
2. Bansal S., Chauhan V., Sharma S., Maheshwari R., Juyal A., Raghuvanshi S. Evaluation of hydroxyapatite and beta-tricalcium phosphate mixed with bone marrow aspirate as a bone graft substitute for posterolateral spinal fusion. Indian J Orthop 2009, 43:234-239.
3. Dai L.Y., Jiang L.S. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up. Spine (Phila Pa 1976) 2008, 33:1299-1304.
4. Lerner T., Bullmann V., Schulte T.L., Schneider M., Liljenqvist U. A level-1 pilot study to evaluate of ultraporous beta-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis. Eur Spine J 2009, 18:170-179.
5. Dai L.Y., Jiang L.S. Anterior cervical fusion with interbody cage containing beta-tricalcium phosphate augmented with plate fixation: a prospective randomized study with 2-year follow-up. Eur Spine J 2008, 17:698-705.
6. Epstein N.E. A preliminary study of the efficacy of Beta tricalcium phosphate as a bone expander for instrumented posterolateral lumbar fusions. J Spinal Disord Tech 2006, 19:424-429.
7. Epstein N.E. An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate. Spine J 2008, 8:882-887.
8. Epstein N.E. Fusion rates and SF-36 outcomes after multilevel laminectomy and noninstrumented lumbar fusions in a predominantly geriatric population. J Spinal Disord Tech 2008, 21:159-164.
9. Becker S., Maissen O., Ponomarev I., et al. Osteopromotion with a plasmatransglutaminase on a beta-TCP ceramic. J Mater Sci Mater Med 2008, 19:659-665.
10. Walsh W.R., Vizesi F., Cornwall G.B., Bell D., Oliver R., Yu Y. Posterolateral spinal fusion in a rabbit model using a collagen-mineral composite bone graft substitute. Eur Spine J 2009, 18:1610-1620.
11. Bridwell K.H., Lenke G., McEnery K.W., Baldus C., Blanke K. Anterior fresh frozen structural allografts in the thoracic and lumbar spine. Do they work if combined with posterior fusion and instrumentation in adult patients with kyphosis or anterior column defects? Spine (Phila Pa 1976) 1995, 20:1410-1418.
12. Mroz T.E., Wang J.C., Hashimoto R., et al. Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976) 2010, 35:S86-S104.
13. Rihn J.A., Patel R., Makda J., et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 2009, 9:623-629.
14. Burak M.O., Vijay A., Erin N., et al. Two-year clinical and radiographic success of minimally invasive lateral transpsoas approach for the treatment of degenerative lumbar conditions. SAS J 2010, 4:41-46.
15. Oliveira L., Marchi L., Coutinho E., et al. The use of rh-BMP2 in standalone extreme lateral interbody fusion (XLIF): clinical and radiological results after 24 months follow-up. World Spinal Column J 2010, 1:19-25.
16. Rodgers W.B., Cox C.S., Gerber E.J. Early complications of extreme lateral interbody fusion in the obese. J Spinal Disord Tech 2010, 23:393-397.
17. Rodgers W.B., Gerber E.J., Patterson J.R. Fusion after minimally disruptive ALIF: analysis of XLIF by computed tomography. Spine Arthroplasty Soc J 2010, 4:37-40.
18. Dhall S.S., Wang M.Y., Mummaneni P.V. Clinical and radiographic comparison of mini-open transforaminal lumbar interbody fusion with open transforaminal lumbar interbody fusion in 42 patients with long-term follow-up. J Neurosurg Spine 2008, 9:560-565.
19. Gill K., Blumenthal S.L. Posterior lumbar interbody fusion. A 2-year follow-up of 238 patients. Acta Orthop Scand Suppl 1993, 251:108-110.
20. Hackenberg L., Halm H., Bullmann V., Vieth V., Schneider M., Liljenqvist U. Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results. Eur Spine J 2005, 14:551-558.
21. Lauber S., Schulte T.L., Liljenqvist U., et al. Clinical and radiologic 2-4-year results of transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2. Spine (Phila Pa 1976) 2006, 31:1693-1698.
22. Schuster J.M., Rechtine G., Norvell D.C., et al. The influence of perioperative risk factors and therapeutic interventions on infection rates after spine surgery: a systematic review. Spine (Phila Pa 1976) 2010, 35:S125-S137.